Lidex

Fluocinonide, the active ingredient in Lidex, is a potent glucocorticoid corticosteroid presented as a topical formulation for cutaneous use. It is indicated for inflammatory skin conditions, reducing redness, swelling, and itching in patients with eczema, psoriasis, dermatitis, and related disorders. Applied directly to the affected area, it modulates local immune responses with minimal systemic absorption when used as directed.

GNH USA supplies Lidex as a licensed, GDP‑compliant supplier to hospitals, pharmacies and clinics worldwide. The company adheres to international quality standards and provides regulatory documentation for export.

Fluocinonide is a topical corticosteroid that acts on inflammatory skin disorders.

- Eczema: Reduces inflammation, itching and redness associated with atopic dermatitis. - Psoriasis: Decreases plaque thickness and scaling in plaque‑type psoriasis. - Dermatitis: Controls acute flare‑ups of contact or seborrheic dermatitis. - Other inflammatory skin disorders: Provides symptomatic relief in conditions such as lichen planus or discoid lupus erythematosus. - Pruritus associated with chronic skin disease: Alleviates persistent itching.

Topical fluocinonide may cause local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site - Skin dryness or peeling - Pruritus or mild irritation - Folliculitis or acneiform eruptions - Localized erythema - Skin atrophy with prolonged use

Serious or Rare Side Effects: - Secondary bacterial, fungal or viral skin infection - Hypothalamic‑pituitary‑adrenal (HPA) axis suppression - Severe allergic reaction (e.g., angioedema, urticaria) - Extensive skin thinning or striae formation - Delayed wound healing - Systemic glucocorticoid effects with extensive application

Use Lidex only under medical supervision and follow prescribed instructions.

- Avoid application to infected, ulcerated or broken skin: risk of systemic absorption and infection. - Limit use on large body surface areas: reduces potential systemic effects. - Use the lowest effective potency and shortest duration needed for control. - Monitor for signs of adrenal suppression, especially with prolonged therapy. - Discontinue if severe irritation or allergic reaction occurs. - Store at room temperature: keep in the original container, protect from moisture and light.

Fluocinonide may interact with other agents that affect immune function or skin integrity.

Major Interactions (Avoid): - Systemic corticosteroids: additive risk of systemic glucocorticoid effects. - Cyclosporine or other potent immunosuppressants: increased immunosuppression and infection risk.

Moderate Interactions (Monitor Closely):\n- Antifungal or antiviral topical agents: may alter absorption and increase irritation. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied to the same area: potential for enhanced local irritation. - Live vaccines: topical steroids may diminish local immune response to the vaccine.